Healthcare & Pharmaceuticals Conferences

Healthcare & Pharmaceuticals Trade Shows & Conferences by Country

Latest on 112-based emergency call legislation and end to end security

Date: 21-Oct-14 to 21-Oct-14
Location: United Kingdom
Automotive will be the strongest growing segment for machine to machine (M2M) over the next few years, according to ABI research, which forecasts that module shipments to auto OEMs will grow from 6 million units in 2013 to 30 million in 2018. Regulatory initiatives like eCall in Europe, ERA GLONASS in Russia, also demonstrates the growth and momentum in the sector along with the much publicised “connected car” trend which is likely to lead to 100% penetration of the technology in the very near future. SMi's masterclass hosted by Gemalto will reflect the status on both eCall and ERA GLONASS in line with announcements made in July. The 2nd part of this course will provide insight into the methods of securing end-to-end communication and protect identity using the latest solutions ...


Date: 20-Oct-14 to 21-Oct-14
Location: London / United Kingdom
With the global COPD market forecasted to reach a value of $15.6 billion by 2019, COPD 2014 comes at a perfect time to provide the industry with a niche platform for discussion and a forum to learn from key visionaries in the field of COPD. The latest instalment in the successful series has evolved to include topical and current sessions, such as Patient Care and The Future of COPD, as well as presenting attendees with in-depth information on exacerbation and comorbidities, ensuring a successful clinical trial design and challenges in drug development and market access.

The Orphan Drugs and Rare Diseases

Date: 20-Oct-14 to 21-Oct-14
Location: London / United Kingdom
SMi Group is proud to announce it will be hosting the 3rd annual conference on Orphan Drugs and Rare Diseases and bringing together leading experts and companies such as Novabiotics, Pfizer, AstraZeneca, GMP Orphan SAS, Genethon and M&C Saatchi and many more to discuss the latest developments in the market.

Ultra-Sensitivity Single-Molecule Array (Simoa) Technology for the Detection of Blood-Based Biomarkers in Neurology or Neurodegeneration

Date: 21-Oct-14 to 21-Oct-14
Symposium Course Description : Dr. Henrik Zetterberg (Sahlgrenska University) will provide an overview of the principles of the Simoa technology developed by Quanterix, Inc. Quanterix has developed the first total tau assay for blood and Dr. Zetterberg will discuss case studies of the use of this assay in mild traumatic brain injury and sport-related concussion. In addition, he will describe the use of the Simoa technology for the development of a custom assay for neurofilament light chain (NFL) in blood. He will then describe the application of Simoa technology to other key neurological and neurodegenerative biomarkers. Dr. Andreas Jeromin, Quanterix, will discuss the current status of development of blood-based biomarkers in central nervous system (CNS), and the importance of ...

Safe and Secure Hospitals Conference

Date: 19-Oct-14 to 21-Oct-14
Location: Australia
A national Conference promoting a safe and secure environment for the hospital and healthcare community

3rd International Summit on Toxicology & Applied Pharmacology

Date: 20-Oct-14 to 22-Oct-14
The 3rd International Summit on Toxicology & Applied Pharmacology (Toxicology-2014) scheduled for October 20-22, 2014 in Chicago, USA. The conference was titled: “New Challenges and Innovations in Pharmacological and Toxicological Sciences”.

Evolution Summit

Date: 20-Oct-14 to 22-Oct-14
Location: Monaco
This summit will be discussing the issues and challenges the pharmaceutical industry is currently facing, pertaining to getting drugs to market. Attendee titles include the heads of clinical operations, trials, research, and project management, as well as vendor outsourcing. These attendees will be coming from mid-size Pharmaceutical, biopharma and biotech companies within the European market. Along with key sessions discussing relevant and timely topics, there will be an opportunity to have individual meetings between the attendees and vendors. These solution provider’s categories include contract research, clinical data management, clinical monitoring and central laboratory services.

10th Annual OPEX and Quality in Pharma and Biotech

Date: 20-Oct-14 to 22-Oct-14
Location: Berlin / Germany
A firm understanding of the regulations surrounding quality and how to maintain a unified approach from start to finish is essential. Join us in Berlin to examine this link and meet with many other industry professionals. SPECIAL FEATURES -Interactive PRE-CONFERENCE workshops -Thoughts OUTSIDE THE BOX -Benchmarking and learning from other industries -Practical CASE STUDIES -Active Participation of Attendees -Focused PANEL DISCUSSIONS REASONS TO ATTEND -Bridging Opex and Quality -GMP and GDP regulations -Modelling of Design Space -Supply Chain Risk Assessment -Change Management across the organisation -Embedding a culture of Continuous Improvement -Continuous Process Verification and Process Validation Guidelines


Date: 20-Oct-14 to 23-Oct-14
Location: Atlanta / Georgia / United States
Medtrade Spring is the second largest (Medtrade is the largest) tradeshow in the U.S. focused exclusively on the home medical equipment market. Medtrade Spring is designed to give today's providers the highest quality educational, networking and advocacy opportunities and the largest selection of HME products under one roof. Medtrade Spring 2014 Mandalay Bay Convention Center Las Vegas, NV Expo March 11-12, 2014 Conference March 10-12, 2014 Medtrade Spring connects the HME industry The 2013 show brought together thousands of home medical equipment providers, home health care professionals, and leading manufacturers of home health care products and technology. Medtrade shows continue to be the largest forums for HME products and services, educational sessions on ...

4th African Regulatory Conference

Date: 22-Oct-14 to 23-Oct-14
Location: Dakar / Senegal
This is the 4th DIA African Regulatory Conference (ARC) co-organised by the Drug Information Association (DIA) and the IFPMA’s African Regulatory Network (ARN). IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) represents the researchbased pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 1.3 million employees strive to develop and provide innovative medicines, biological products, and vaccines that improve patients’ lives worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. The ARN is an ad-hoc network of the Regulatory Policy and Technical Standards Committee (...